Adipose Tissue Metabolism and Cardiovascular Health Outcomes

Adipose tissue functions far beyond its traditional role as a passive energy reservoir, acting instead as a dynamic endocrine organ that modulates systemic metabolism and vascular health. Through the secretion of bioactive lipids, peptides and cytokines—collectively known as adipokines—adipose depots influence lipid handling, insulin sensitivity and inflammatory tone. In healthy states, balanced adipocyte differentiation and adequate angiogenesis permit effective lipid buffering and insulin‐mediated suppression of lipolysis, thereby protecting vascular endothelium from lipotoxic injury. Conversely, adipocyte hypertrophy, extracellular matrix remodelling and immune cell infiltration engender adipose dysfunction, characterised by aberrant adipokine profiles, chronic low‐grade inflammation and oxidative stress. These shifts contribute to atherogenesis, myocardial remodelling and impaired microvascular integrity. Emerging evidence emphasises depot‐specific differences—where visceral fat is tightly linked to insulin resistance and endothelial dysfunction, while metabolically active brown and beige fat may confer cardio‐protective effects through enhanced fatty acid β‐oxidation. Unravelling the molecular crosstalk between adipose tissue and cardiovascular systems is pivotal for developing targeted interventions to reduce the global burden of cardiometabolic disease.

Research from Nature Portfolio

Recent work has elucidated how a disrupted balance between leptin and adiponectin underlies systemic inflammation and oxidative stress in metabolic syndrome. A low adiponectin-to-leptin ratio, indicative of adipose tissue dysfunction, correlates with elevated markers of lipid peroxidation and acute‐phase reactants. This dysfunction amplifies endothelial injury and propagates a pro-inflammatory milieu, thereby accelerating atherosclerotic progression. The study highlights the ratio as a functional biomarker, opening avenues for stratified risk assessment and therapeutic modulation of adipokine signalling to ameliorate cardiovascular outcomes.

Adipose Tissue Metabolism and Cardiovascular Health Outcomes publication trend

The graph below shows the total number of articles in adipose tissue metabolism and cardiovascular health outcomes across all publications each year (not limited to Nature Index journals).

Technical terms

Adipokines: Bioactive molecules secreted by adipose tissue that regulate metabolism, inflammation and vascular function.

β-oxidation: Mitochondrial metabolic pathway by which fatty acids are broken down to generate acetyl-CoA for energy production.

Leptin-to-adiponectin ratio: A biomarker reflecting adipose tissue health; low ratios indicate dysfunctional, pro-inflammatory adipose depots.

Metabolic memory: Persistent epigenetic alterations induced by prior metabolic insults, sustaining pathogenic gene expression in cells.

Insulin resistance: A state in which peripheral tissues exhibit reduced responsiveness to insulin, often leading to dyslipidaemia and vascular impairment.

Mitochondrial translocation: The movement of signalling proteins into mitochondria, which can modulate oxidative phosphorylation and cell viability.

References

1. Involvement of the leptin-adiponectin axis in inflammation and oxidative stress in the metabolic syndrome. Scientific Reports (2017).
2. Metabolic memory: mechanisms and diseases. Signal Transduction and Targeted Therapy (2024).
3. Adipsin inhibits Irak2 mitochondrial translocation and improves fatty acid β-oxidation to alleviate diabetic cardiomyopathy. Military Medical Research (2023).
4. Obesity: A Chronic Low-Grade Inflammation and Its Markers. Cureus (2022).